Imatinib Mesylate Therapy in Patients of Chronic Myeloid Leukemia with Philadelphia Chromosome Positive: An Experience from Eastern India

Imatinib inhibits constitutively active BCR-ABL tyrosine kinase of chronic myeloid leukemia (CML). In a long term study it was found superior to interferon alfa plus cytarabine for newly diagnosed CML in the chronic phase. However, till date there is no major study to evaluate eastern Indian CML pat...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Mukhopadhyay, A., Dasgupta, S., Mukhopadhyay, S., Bose, C. K., Sarkar, S., Gharami, F., Koner, S., Basak, J., Roy, U. K.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Springer-Verlag 2011
Aiheet:
Original Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3332275/
https://ncbi.nlm.nih.gov/pubmed/23730014
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12288-011-0108-9
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia